$LHDX EG: +102.00% yoy RG: +22,623% yoy

See the charts on twitter:

https://twitter.com/peregreine/status/1502290683419365380

#PeregrineWatchlist

1. Micro-cap $LHDX reported earnings after the bell yesterday

Loss: -.03 cents per share
eBEAT: +94.50%
rBEAT: +111.50%
Earnings Growth: +102% yoy
Revenue Growth: +22,623% yoy
Raised Guidance: +28.60%

Peregrine Trader
@peregreine
·
2m
Replying to
@peregreine
2) EstimatesLucira Health $LHDX reported a 4th Quarter December 2021 loss of $0.03 per share on revenue of $61.1 million. The consensus estimate was a loss of $0.55 per share on revenue of $28.9 million.
Peregrine Trader
@peregreine
·
2m
3) $LHDX said it expects first quarter revenue of $80.0 million to $85.0 million and 2022 revenue in excess of $450.0 million. The current consensus revenue estimate is $64.15 million for the quarter ending 31 MAR 22 and revenue of $273.37 million for the year ending 31 DEC 22
Peregrine Trader
@peregreine
·
2m
4) $LHDX Achieved net revenue of $61.1 million for the fourth quarter of 2021, representing approximately 300% sequential growth over the preceding quarter

Recorded full year revenue of $93.1 million for 2021, the Company’s first full year of commercialization
Peregrine Trader
@peregreine
·
2m
5) $LHDX Increased manufacturing output through the Dominican Republic-based plant resulted in positive gross profit and margin for both the fourth quarter and the full year 2021
Peregrine Trader
@peregreine
·
2m
6) $LHDX Secured contract with Canadian healthcare company, Switch Health, to provide more than 2 million at-home COVID-19 test kits in 2022

1 Like